-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ILYX-002 in Keratoconjunctivitis Sicca (Dry Eye)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ILYX-002 in Keratoconjunctivitis Sicca (Dry Eye) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ILYX-002 in Keratoconjunctivitis Sicca (Dry Eye) Drug Details: ILYX-002 is...